Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs

키워드

참고문헌 (41)

1. Messias EL, "Epidemiology of schizophrenia: review of findings and myths", Psychiatr Clin North Am, 30, pp.323~338 (2007)[DOI]
2. Ganesan Venkatasubramanian, "Understanding Schizophrenia as a Disorder of Consciousness: Biological Correlates and Translational Implications from Quantum Theory Perspectives", Clinical Psychopharmacology and Neuroscience, 13(1), pp.36~47 (2015), 대한정신약물학회
3. 노대영, "Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison", Clinical Psychopharmacology and Neuroscience, 13(3), pp.275~282 (2015), 대한정신약물학회
4. 김성진, "The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia", Clinical Psychopharmacology and Neuroscience, 13(3), pp.288~295 (2015), 대한정신약물학회
5. Anupa A. Vijayakumari, "Effect of Polymorphisms of Three Genes Mediating Monoamine Signalling on Brain Morphometry in Schizophrenia and Healthy Subjects", Clinical Psychopharmacology and Neuroscience, 13(1), pp.68~82 (2015), 대한정신약물학회
6. Nagahara AH, "Potential therapeutic uses of BDNF in neurological and psychiatric disorders", Nat Rev Drug Discov, 10, pp.209~219 (2011)[DOI]
7. Boskovic M, "Oxidative stress in schizophrenia", Curr Neuropharmacol, 9, pp.301~312 (2011)[DOI]
8. Ng F, "Oxidative stress in psychiatric disorders: evidence base and therapeutic implications", Int J Neuropsychopharmacol, 11, pp.851~876 (2008)
9. Virit O, "A defect in the antioxidant defense system in schizophrenia", Neuropsychobiology, 60, pp.87~93 (2009)[DOI]
10. Erel O, "A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation", Clin Biochem, 37, pp.277~285 (2004)[DOI]
11. Erel O, "A new automated colorimetric method for measuring total oxidant status", Clin Biochem, 38, pp.1103~1111 (2005)[DOI]
12. Camkurt MA, "Probable preventive effects of placenta from oxidative stress; Evaluation of total antioxidant status, total oxidant status and oxidative stress index in fetal cord blood during the delivery", Psychiatry Res, 240, pp.222~225 (2016)[DOI]
13. Pazvantoglu O, "Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile", Psychiatry Clin Neurosci, 63, pp.693~700 (2009)[DOI]
14. Ustundag B, "Total antioxidant response in patients with schizophrenia", Psychiatry Clin Neurosci, 60, pp.458~464 (2006)[DOI]
15. Sertan Copoglu U, "Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients", Psychiatry Res, 229, pp.200~205 (2015)[DOI]
16. Bahceci B, "Prolidase activity and oxidative stress in patients with schizophrenia: a preliminary study", J Pak Med Assoc, 65, pp.131~135 (2015)
17. Devanarayanan S, "Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study", Clin Chem Lab Med, 54, pp.447~452 (2016)
18. Cremers CM, "Oxidant sensing by reversible disulfide bond formation", J Biol Chem, 288, pp.26489~26496 (2013)[DOI]
19. Jones DP, "Measuring the poise of thiol", disulfide couples in vivo, 2009, pp.47, 1329~1338
20. Erel O, "A novel and automated assay for thiol", disulphide homeostasis, 2014, pp.47, 326~332
21. Motor S, "Evaluation of total antioxidant status, total oxidant status and oxidative stress index in patients with alopecia areata", Int J Clin Exp Med, 7, pp.1089~1093 (2014)
22. Al-Chalabi BM, "Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients", Neuropsychobiology, 59, pp.8~11 (2009)[DOI]
23. Evans DR, "Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment", Prostaglandins Leukot Essent Fatty Acids, 69, pp.393~399 (2003)[DOI]
24. Wei Z, "Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide", J Neurosci Res, 73, pp.364~368 (2003)[DOI]
25. Park SW, "Effects of antipsychotic drugs on BDNF, GSK-<TEX>$3{\beta}$<", TEX>, and <TEX>${\beta}$<, Neurosci Res, pp.2011, 71[DOI]
26. Moustafa AA, "Homocysteine levels in schizophrenia and affective disorders-focus on cognition", Front Behav Neurosci, 8, pp.343~ (2014)
27. Levine J, "High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.1181~1191 (2005)[DOI]
28. Kevere L, "Elevated serum levels of homocysteine as an early prognostic factor of psychiatric disorders in children and adolescents", Schizophr Res Treatment, 2012, pp.373261~ (2012)
29. Bouaziz N, "Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics", Psychiatry Res, 179, pp.24~29 (2010)[DOI]
30. Adler Nevo G, "Homocysteine levels in adolescent schizophrenia patients", Eur Neuropsychopharmacol, 16, pp.588~591 (2006)[DOI]
31. Gysin R, "Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence", Proc Natl Acad Sci U S A, 104, pp.16621~16626 (2007)[DOI]
32. Matsuzawa D, "Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study", PLoS One, 3, pp.e1944~ (2008)[DOI]
33. Raffa M, "Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients", BMC Psychiatry, 11, pp.124~ (2011)[DOI]
34. Altuntas I, "Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients", Clin Chem Lab Med, 38, pp.1277~1281 (2000)
35. Dietrich-Muszalska A, "Oxidative", nitrative modifications of plasma proteins and thiols from patients with schizophrenia, 2009, pp.59, 1~7
36. Ben Othmen L, "Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.155~159 (2008)[DOI]
37. Yao JK, "Altered glutathione redox state in schizophrenia", Dis Markers, 22, pp.83~93 (2006)[DOI]
38. Akanji AO, "Associations of blood homocysteine concentrations in Arab schizophrenic patients", Clin Biochem, 40, pp.1026~1031 (2007)[DOI]
39. Parikh V, "Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain", J Psychiatr Res, 37, pp.43~51 (2003)[DOI]
40. Pillai A, "Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain", J Psychiatr Res, 41, pp.372~386 (2007)[DOI]
41. Dakhale G, "Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics", Neuropsychobiology, 49, pp.205~209 (2004)[DOI]

관련 논문AI추천